Bayer launches US$59m expansion in Beijing
Bayer has launched a 50-million-euro (US$59 million) expansion project for its production and supply facilities in Beijing.
Bayer began construction of a 50-million-euro (US$59 million) production and supply plant on Wednesday to expand its existing site in Beijing to enhance a stable supply of prescription drugs.
New production lines are expected to become operational by the end of 2022 and are set to increase the annual output of the Beijing site by about 40 percent.
Managing chronic disease is a key segment of the "Healthy China 2030" blueprint, and a detailed action plan was released by the State Council last July.
Ensuring a continuous supply of commonly used drugs for chronic diseases at an accessible price has been the focus of China's drug administration body and major drug companies.
“In the face of huge challenges caused by the COVID-19 pandemic, the initiative fully demonstrates Bayer’s unswerving confidence and commitment to China, and again shows our aspiration of serving more Chinese patients and determination to contribute to building a healthy China," said Wei Jiang, executive vice president and president of Bayer Pharmaceuticals Region China & APAC and president of Bayer Group China.
Bayer Pharmaceuticals established its first plant in the Beijing Economic-Technological Development Area in 1995 and has been producing a wide range of treatments for diabetes, hypertension and other cardiovascular diseases.
In 2016, it became the largest pharmaceuticals packaging site in Bayer Pharmaceuticals Division’s global production network.
“Through this project, we will continue to connect world-leading production technologies with digital solutions and universal quality control standards at our Beijing site, thus delivering our high-quality products to more Chinese patients,” said Soenke Zornig, vice president and head of product supply China, Bayer Pharmaceuticals Division.
The expansion project covers production space and auxiliary technical area, which will be equipped with automated production lines and a logistics facility.
